KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EBIT (2016 - 2025)

Historic EBIT for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to -$82.6 million.

  • Exact Sciences' EBIT rose 9057.51% to -$82.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$206.3 million, marking a year-over-year increase of 8032.83%. This contributed to the annual value of -$206.3 million for FY2025, which is 8032.83% up from last year.
  • According to the latest figures from Q4 2025, Exact Sciences' EBIT is -$82.6 million, which was up 9057.51% from -$25.5 million recorded in Q3 2025.
  • Exact Sciences' 5-year EBIT high stood at $6.8 million for Q3 2023, and its period low was -$876.4 million during Q4 2024.
  • Its 5-year average for EBIT is -$146.0 million, with a median of -$101.4 million in 2024.
  • Per our database at Business Quant, Exact Sciences' EBIT skyrocketed by 10496.1% in 2023 and then tumbled by 119177.19% in 2024.
  • Quarter analysis of 5 years shows Exact Sciences' EBIT stood at -$221.4 million in 2021, then skyrocketed by 46.32% to -$118.9 million in 2022, then soared by 42.93% to -$67.8 million in 2023, then tumbled by 1191.77% to -$876.4 million in 2024, then surged by 90.58% to -$82.6 million in 2025.
  • Its last three reported values are -$82.6 million in Q4 2025, -$25.5 million for Q3 2025, and -$2.1 million during Q2 2025.